About
Bioengineered Vessels
Areas of Focus
Categories
Tissue EngineeringNorth & South Carolina
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
959
By Phase
PHASE3: 3PHASE2: 2PHASE2/PHASE3: 1NA: 2PHASE1: 1
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 2RECRUITING: 1APPROVED_FOR_MARKETING: 1TEMPORARILY_NOT_AVAILABLE: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05908084Lead Sponsor
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
PHASE3Recruiting
150 participants
Started: Sep 7, 2023 · Completed: Oct 31, 2027
NCT05873959Lead Sponsor
An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma
N/ACompleted
17 participants
Started: May 1, 2023 · Completed: Jan 15, 2024
NCT04135417Lead Sponsor
Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis
PHASE2Completed
30 participants
Started: Nov 12, 2019 · Completed: Mar 2, 2022
NCT03005418Lead Sponsor
Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
PHASE2/PHASE3Active, not recruiting
72 participants
Started: Sep 1, 2018 · Completed: Sep 1, 2027
NCT03183245Lead Sponsor
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
PHASE3Active, not recruiting
240 participants
Started: Sep 29, 2017 · Completed: Sep 30, 2025
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...